Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas

Non-small cell lung cancer (NSCLC) is still the leading cause of cancer death worldwide. Despite the introduction of tyrosine kinase inhibitors and immunotherapeutic approaches, there is still an urgent need for novel strategies to improve patient survival. ROS1, a tyrosine kinase receptor endowed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccardo, Federica, Barutello, Giuseppina, Petito, Angela, Tarone, Lidia, Conti, Laura, Arigoni, Maddalena, Musiu, Chiara, Izzo, Stefania, Volante, Marco, Longo, Dario Livio, Merighi, Irene Fiore, Papotti, Mauro, Cavallo, Federica, Quaglino, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349290/
https://www.ncbi.nlm.nih.gov/pubmed/32268572
http://dx.doi.org/10.3390/vaccines8020166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349290/
https://www.ncbi.nlm.nih.gov/pubmed/32268572
http://dx.doi.org/10.3390/vaccines8020166

Ejemplares similares